We are live on ! Find out more
SPRB

Spruce Biosciences
SPRB

43 hedge funds and large institutions have $34.4M invested in Spruce Biosciences in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less funds holding

Funds holding: 50 → 43 (-7)

56% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 18

57% less capital invested

Capital invested by funds: $79M → $34.4M (-$44.6M)

64% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 11

Holders
43
Holders Change
-7
Holders Change %
-14%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
8
Reduced
18
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$271K
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$220K
3
State Street
State Street
Massachusetts
+$195K
4
Renaissance Technologies
Renaissance Technologies
New York
+$178K
5
BCM
Bridgeway Capital Management
Texas
+$90.4K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$542K
2
Goldman Sachs
Goldman Sachs
New York
-$467K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$318K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$267K
5
LGM
Logos Global Management
California
-$248K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$24K +$17.5K +94 +134%
Morgan Stanley
27
Morgan Stanley
New York
$22K -$2.42K -13 -8%
Fidelity Investments
28
Fidelity Investments
Massachusetts
$14K -$267K -1,434 -94%
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$12K -$186 -1 -1%
TRCT
30
Tower Research Capital (TRC)
New York
$11K +$930 +5 +8%
Bank of America
31
Bank of America
North Carolina
$10K -$194K -1,043 -94%
Wells Fargo
32
Wells Fargo
California
$10K -$11.3K -61 -48%
AIG
33
American International Group
New York
$9K -$930 -5 -8%
UBS Group
34
UBS Group
Switzerland
$8K -$3.54K -19 -27%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$8K +$558 +3 +6%
PHK
36
Point72 Hong Kong
Hong Kong
$6K +$7.07K +38 New
Citigroup
37
Citigroup
New York
$3K -$2.42K -13 -45%
Legal & General Group
38
Legal & General Group
United Kingdom
$2K – – –
AB
39
Amalgamated Bank
New York
$2K +$2.6K +14 New
AF
40
Amalgamated Financial
New York
$2K +$2.6K +14 New
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$1K -$2.98K -16 -67%
AIP
42
Ameritas Investment Partners
Nebraska
$1K – – –
TWA
43
TCI Wealth Advisors
Arizona
$1K – – –
Acadian Asset Management
44
Acadian Asset Management
Massachusetts
– -$318K -957 Closed
Jane Street
45
Jane Street
New York
– -$160K -479 Closed
TSS
46
Two Sigma Securities
New York
– -$128K -383 Closed
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
– -$122K -364 Closed
Bank of Montreal
48
Bank of Montreal
Ontario, Canada
– -$132K -350 Closed
PCM
49
Prelude Capital Management
New York
– -$75K -223 Closed
Squarepoint
50
Squarepoint
New York
– -$61K -181 Closed
1
2
3

SPRB Hedge Fund Activity: Q1 2022 in Review

43 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Spruce Biosciences (SPRB) for Q1 2022, worth a combined $34.4M — down 57% from $79M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of SPRB and 4 opened new positions — a net loss of 7 holders — while 18 trimmed existing stakes and 8 added.

The largest buyer was BlackRock, adding an estimated $271K. The largest seller was Vanguard Group, cutting an estimated $542K.

  • 43 institutional investors held Spruce Biosciences (SPRB) as of Q1 2022, down from 50 in Q4 2021.
  • Funds reported $34.4M of Spruce Biosciences stock for Q1 2022, down 57% quarter-over-quarter.
  • 4 funds opened new Spruce Biosciences positions in Q1 2022 and 11 closed out, a net change of -7 holders.
  • The largest Spruce Biosciences buyer in Q1 2022 was BlackRock, an estimated $271K added.
  • The largest Spruce Biosciences seller in Q1 2022 was Vanguard Group, an estimated $542K sold.

Based on aggregated 13F filings for Q1 2022.